您的购物车当前为空
别名 ISC27864
Zaloglanstat (ISC-27864) is a selective, orally active mPGES-1 inhibitor with an IC50 of 5 nM against human mPGES-1, demonstrating analgesic effects in osteoarthritis and inflammatory arthritis.


为众多的药物研发团队赋能,
让新药发现更简单!
Zaloglanstat (ISC-27864) is a selective, orally active mPGES-1 inhibitor with an IC50 of 5 nM against human mPGES-1, demonstrating analgesic effects in osteoarthritis and inflammatory arthritis.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,480 | 现货 | |
| 5 mg | ¥ 3,290 | 现货 | |
| 10 mg | ¥ 4,730 | 现货 | |
| 25 mg | ¥ 7,260 | 现货 | |
| 50 mg | ¥ 9,790 | 现货 | |
| 100 mg | ¥ 13,200 | 现货 | |
| 200 mg | ¥ 17,800 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,650 | 现货 |
Zaloglanstat 相关产品
| 产品描述 | Zaloglanstat(ISC-27864) 是一种选择性和口服有效的mPGES-1抑制剂,对人mPGES-1的IC50=5 nM,在骨关节炎和炎症性关节炎中具有镇痛效果。 |
| 体外活性 | Zaloglanstat 对人重组 mPGES-1 活性及 A549 细胞中的 IL-1β 均具有选择性抑制作用,IC50 均为 5 nM,对 COX-1 和 COX-2 则未表现出显著抑制作用(IC₅₀ >10 μM) [1]。在 IL-1β 诱导的 A549 细胞与人滑膜成纤维细胞模型中,Zaloglanstat 可以剂量依赖性地抑制 PGE₂ 的释放,其 IC₅₀ 值小于 10 nM [1]。 |
| 别名 | ISC27864 |
| 分子量 | 452.86 |
| 分子式 | C21H20ClF3N4O2 |
| CAS No. | 1513852-12-4 |
| Smiles | CC(C)(C)C(=O)NCc1ccc(Cl)c(c1)-c1nn(-c2ccc(cc2)C(F)(F)F)c(=O)[nH]1 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 200 mg/mL (441.64 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容